A melanin‐independent interaction between Mc1r and Met signaling pathways is required for HGF‐dependent melanoma
Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP‐dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well‐described melanoma risk factor. M...
Saved in:
Published in | International journal of cancer Vol. 136; no. 4; pp. 752 - 760 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
15.02.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0020-7136 1097-0215 1097-0215 |
DOI | 10.1002/ijc.29050 |
Cover
Loading…
Abstract | Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP‐dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well‐described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV‐induced melanoma. C57BL/6‐Mc1r+/+‐HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra‐follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA‐induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6‐Mc1re/e animals which have a non‐functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6‐Mc1re/e‐HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6‐Mc1r+/+‐HGF mice, hyperpigmentation was not observed and there were few extra‐follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6‐Mc1re/+‐HGF mice were black and hyperpigmented and, although extra‐follicular melanocytes and skin melanin content were similar to C57BL/6‐Mc1r+/+‐HGF animals, they developed UV‐induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin‐independent interaction between Mc1r and Met signaling pathways is required for HGF‐dependent melanoma and postulate that this pathway is involved in human melanoma.
What's new?
Melanocortin 1 receptor (MC1R), which plays a central role in the production of melanin, is subject to marked genetic variation, with certain variants increasing melanoma risk through fair skin phenotype. Others MCR1 variants, however, influence melanoma risk through pigment‐independent alterations. Such variants may include those that affect interactions between Mc1r and hepatocyte growth factor (HGF)/Met signaling, as suggested by this investigation of Mcr1 deficiency in a UV‐induced melanoma mouse model. HGF has been implicated in tumor escape from B‐RAF inhibitors in human melanoma, and MET is a target for melanoma therapy, suggesting potential therapeutic significance for the findings. |
---|---|
AbstractList | Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP-dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well-described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV-induced melanoma. C57BL/6-Mc1r+/+-HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra-follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA-induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6-Mc1re/e animals which have a non-functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6-Mc1re/e-HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6-Mc1r+/+-HGF mice, hyperpigmentation was not observed and there were few extra-follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6-Mc1re/+-HGF mice were black and hyperpigmented and, although extra-follicular melanocytes and skin melanin content were similar to C57BL/6-Mc1r+/+-HGF animals, they developed UV-induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma and postulate that this pathway is involved in human melanoma. What's new? Melanocortin 1 receptor (MC1R), which plays a central role in the production of melanin, is subject to marked genetic variation, with certain variants increasing melanoma risk through fair skin phenotype. Others MCR1 variants, however, influence melanoma risk through pigment-independent alterations. Such variants may include those that affect interactions between Mc1r and hepatocyte growth factor (HGF)/Met signaling, as suggested by this investigation of Mcr1 deficiency in a UV-induced melanoma mouse model. HGF has been implicated in tumor escape from B-RAF inhibitors in human melanoma, and MET is a target for melanoma therapy, suggesting potential therapeutic significance for the findings. Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP-dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well-described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV-induced melanoma. C57BL/6-Mc1r+/+-HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra-follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA-induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6-Mc1re/e animals which have a non-functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6-Mc1re/e-HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6-Mc1r+/+-HGF mice, hyperpigmentation was not observed and there were few extra-follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6-Mc1re/+-HGF mice were black and hyperpigmented and, although extra-follicular melanocytes and skin melanin content were similar to C57BL/6-Mc1r+/+-HGF animals, they developed UV-induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma and postulate that this pathway is involved in human melanoma. Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP‐dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well‐described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV‐induced melanoma. C57BL/6‐Mc1r+/+‐HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra‐follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA‐induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6‐Mc1re/e animals which have a non‐functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6‐Mc1re/e‐HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6‐Mc1r+/+‐HGF mice, hyperpigmentation was not observed and there were few extra‐follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6‐Mc1re/+‐HGF mice were black and hyperpigmented and, although extra‐follicular melanocytes and skin melanin content were similar to C57BL/6‐Mc1r+/+‐HGF animals, they developed UV‐induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin‐independent interaction between Mc1r and Met signaling pathways is required for HGF‐dependent melanoma and postulate that this pathway is involved in human melanoma. What's new? Melanocortin 1 receptor (MC1R), which plays a central role in the production of melanin, is subject to marked genetic variation, with certain variants increasing melanoma risk through fair skin phenotype. Others MCR1 variants, however, influence melanoma risk through pigment‐independent alterations. Such variants may include those that affect interactions between Mc1r and hepatocyte growth factor (HGF)/Met signaling, as suggested by this investigation of Mcr1 deficiency in a UV‐induced melanoma mouse model. HGF has been implicated in tumor escape from B‐RAF inhibitors in human melanoma, and MET is a target for melanoma therapy, suggesting potential therapeutic significance for the findings. Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP-dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well-described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV-induced melanoma. C57BL/6-Mc1r+/+-HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra-follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA-induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6-Mc1re/e animals which have a non-functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6-Mc1re/e-HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6-Mc1r+/+-HGF mice, hyperpigmentation was not observed and there were few extra-follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6-Mc1re/+-HGF mice were black and hyperpigmented and, although extra-follicular melanocytes and skin melanin content were similar to C57BL/6-Mc1r+/+-HGF animals, they developed UV-induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma and postulate that this pathway is involved in human melanoma.Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP-dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well-described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV-induced melanoma. C57BL/6-Mc1r+/+-HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra-follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA-induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6-Mc1re/e animals which have a non-functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6-Mc1re/e-HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6-Mc1r+/+-HGF mice, hyperpigmentation was not observed and there were few extra-follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6-Mc1re/+-HGF mice were black and hyperpigmented and, although extra-follicular melanocytes and skin melanin content were similar to C57BL/6-Mc1r+/+-HGF animals, they developed UV-induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma and postulate that this pathway is involved in human melanoma. Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well-described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV-induced melanoma. C57BL/6-Mc1r +/+ -HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra-follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA-induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6-Mc1r e/e animals which have a non-functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6-Mc1r e/e -HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6-Mc1r +/+ -HGF mice, hyperpigmentation was not observed and there were few extra-follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6-Mc1r e/+ -HGF mice were black and hyperpigmented and, although extra-follicular melanocytes and skin melanin content were similar to C57BL/6-Mc1r +/+ -HGF animals, they developed UV-induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma and postulate that this pathway is involved in human melanoma. Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP‐dependent pathway. MC1R polymorphisms can impair this process, resulting in a predominance of red phaeomelanin. The red hair, fair skin and UV sensitive phenotype is a well‐described melanoma risk factor. MC1R polymorphisms also confer melanoma risk independent of pigment. We investigated the effect of Mc1r deficiency in a mouse model of UV‐induced melanoma. C57BL/6‐Mc1r +/+ ‐HGF transgenic mice have a characteristic hyperpigmented black phenotype with extra‐follicular dermal melanocytes located at the dermal/epidermal junction. UVB induces melanoma, independent of melanin pigmentation, but UVA‐induced and spontaneous melanomas are dependent on black eumelanin. We crossed these mice with yellow C57BL/6‐Mc1r e/e animals which have a non‐functional Mc1r and produce predominantly yellow phaeomelanin. Yellow C57BL/6‐Mc1r e/e ‐HGF mice produced no melanoma in response to UVR or spontaneously even though the HGF transgene and its receptor Met were expressed. Total melanin was less than in C57BL/6‐Mc1r +/+ ‐HGF mice, hyperpigmentation was not observed and there were few extra‐follicular melanocytes. Thus, functional Mc1r was required for expression of the transgenic HGF phenotype. Heterozygous C57BL/6‐Mc1r e/+ ‐HGF mice were black and hyperpigmented and, although extra‐follicular melanocytes and skin melanin content were similar to C57BL/6‐Mc1r +/+ ‐HGF animals, they developed UV‐induced and spontaneous melanomas with significantly less efficiency by all criteria. Thus, heterozygosity for Mc1r was sufficient to restore the transgenic HGF phenotype but insufficient to fully restore melanoma. We conclude that a previously unsuspected melanin‐independent interaction between Mc1r and Met signaling pathways is required for HGF‐dependent melanoma and postulate that this pathway is involved in human melanoma. What's new? Melanocortin 1 receptor (MC1R), which plays a central role in the production of melanin, is subject to marked genetic variation, with certain variants increasing melanoma risk through fair skin phenotype. Others MCR1 variants, however, influence melanoma risk through pigment‐independent alterations. Such variants may include those that affect interactions between Mc1r and hepatocyte growth factor (HGF)/Met signaling, as suggested by this investigation of Mcr1 deficiency in a UV‐induced melanoma mouse model. HGF has been implicated in tumor escape from B‐RAF inhibitors in human melanoma, and MET is a target for melanoma therapy, suggesting potential therapeutic significance for the findings. |
Author | Noonan, Frances P. Strickland, Faith M. Wielgus, Albert Merlino, Glenn Fabo, Edward C. Wolnicka‐Glubisz, Agnieszka Anver, Miriam |
AuthorAffiliation | 2 Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics, Krakow, Poland 4 Laboratory of Toxicology and Pharmacology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709, USA 1 Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC 20037, USA 3 Department of Dermatology, The Henry Ford Health Sciences Center, One Ford Place, Detroit, MI 48202, USA 5 Pathology/Histotechnology Laboratory Frederick National Laboratory for Cancer Research, Frederick MD 21702, USA 6 Laboratory of Cancer Biology & Genetics, National Cancer Institute, NIH, Bethesda MD 20892, USA |
AuthorAffiliation_xml | – name: 4 Laboratory of Toxicology and Pharmacology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709, USA – name: 5 Pathology/Histotechnology Laboratory Frederick National Laboratory for Cancer Research, Frederick MD 21702, USA – name: 1 Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC 20037, USA – name: 2 Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics, Krakow, Poland – name: 3 Department of Dermatology, The Henry Ford Health Sciences Center, One Ford Place, Detroit, MI 48202, USA – name: 6 Laboratory of Cancer Biology & Genetics, National Cancer Institute, NIH, Bethesda MD 20892, USA |
Author_xml | – sequence: 1 givenname: Agnieszka surname: Wolnicka‐Glubisz fullname: Wolnicka‐Glubisz, Agnieszka organization: Biophysics and Biotechnology, Jagiellonian University – sequence: 2 givenname: Faith M. surname: Strickland fullname: Strickland, Faith M. organization: The Henry Ford Health Sciences Center – sequence: 3 givenname: Albert surname: Wielgus fullname: Wielgus, Albert organization: National Institute of Environmental Health Sciences, NIH – sequence: 4 givenname: Miriam surname: Anver fullname: Anver, Miriam organization: Pathology/Histotechnology Laboratory Frederick National Laboratory for Cancer Research – sequence: 5 givenname: Glenn surname: Merlino fullname: Merlino, Glenn organization: National Cancer Institute, NIH – sequence: 6 givenname: Edward C. surname: Fabo fullname: Fabo, Edward C. organization: Immunology and Tropical Medicine, The George Washington University – sequence: 7 givenname: Frances P. surname: Noonan fullname: Noonan, Frances P. organization: Immunology and Tropical Medicine, The George Washington University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24975581$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9u1DAQxi1URLeFAy-ALHGBQ1o7ie3kglSt6B_UigucLccZb71K7K3tdLU3HoFn5Enw7pYCleDiOcxvPn8z3xE6cN4BQq8pOaGElKd2qU_KljDyDM0oaUVBSsoO0Cz3SCFoxQ_RUYxLQihlpH6BDsu6FYw1dIbSGR5hUM66H9--W9fDCvLjErYuQVA6We9wB2kN4PCNpgEr1-MbSDjahVODdQu8Uul2rTYR24gD3E02QI-ND_jy4jyr_tbc_eRH9RI9N2qI8OqhHqOv5x-_zC-L688XV_Oz60IzWpGiUdw0VFQV6ZgQomk5Z1UpeCc4MNG1QKE1ijFqBNEAzKgGes6N0XVfNpRUx-jDXnc1dSP0OnsIapCrYEcVNtIrK__uOHsrF_5e1iUvOa2ywLsHgeDvJohJjjZqGPIa4KcoKa9YvioXLKNvn6BLP4V8oR1Vc97Sdku9-dPRo5VfgWTg_R7QwccYwDwilMht2DKHLXdhZ_b0CattUtvE8jJ2-N_E2g6w-be0vPo030_8BLRXvVA |
CitedBy_id | crossref_primary_10_1007_s12272_018_1002_x crossref_primary_10_1016_j_jphotobiol_2018_06_005 crossref_primary_10_1016_j_biopha_2017_01_045 crossref_primary_10_1016_j_acthis_2015_06_002 crossref_primary_10_3390_ijms24054360 |
Cites_doi | 10.3727/000000001783986251 10.1038/nature11183 10.1111/pcmr.12157 10.1210/me.2010-0217 10.1111/pcmr.12118 10.1074/jbc.M800480200 10.1158/1541-7786.MCR-11-0436 10.1158/0008-5472.CAN-04-1454 10.1038/jid.2011.21 10.1007/978-3-642-19683-6_1 10.1111/j.1749-6632.2003.tb03200.x 10.1016/j.molcel.2013.08.010 10.1111/exd.12100 10.1038/35095108 10.1002/9781444319651 10.1189/jlb.1206729 10.1038/nature11249 10.1111/j.1600-0749.2006.00315.x 10.1038/jid.2009.258 10.1038/jid.2009.182 10.1038/ncomms1893 10.1016/0092-8674(93)90572-8 10.1038/nature11624 10.1038/jid.2012.59 10.1152/physrev.00044.2003 10.1371/journal.pone.0074883 10.1038/jid.2009.410 10.1093/hmg/ddm191 10.1073/pnas.93.12.5866 10.1152/ajpendo.00217.2011 10.1038/jid.2008.210 10.1002/ijc.25913 10.1016/j.peptides.2007.10.003 10.1038/jid.2010.242 10.1039/b506974b 10.1158/0008-5472.CAN-04-4535 10.1038/nm.3194 10.1074/jbc.M402508200 10.1016/0022-202X(93)90507-E 10.1038/nrm3012 10.1096/fj.10-158485 10.1111/j.0022-202X.2004.23528.x 10.1210/en.2004-0733 10.1038/nature09666 10.1073/pnas.75.11.5395 10.1006/dbio.1997.8738 10.1002/ijc.25804 10.1111/j.0022-202X.2005.23781.x 10.1038/jid.2011.473 10.1038/ng.185 10.1002/humu.20476 10.1126/science.1127515 |
ContentType | Journal Article |
Copyright | 2014 UICC 2014 UICC. |
Copyright_xml | – notice: 2014 UICC – notice: 2014 UICC. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 5PM |
DOI | 10.1002/ijc.29050 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0215 |
EndPage | 760 |
ExternalDocumentID | PMC4262613 3520962731 24975581 10_1002_ijc_29050 IJC29050 |
Genre | article Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIH funderid: CA53765 ; CA92258 ; AR47951 – fundername: US Department of Defense funderid: DAMD17‐01‐1‐1709 – fundername: Melanoma Research Foundation (Established Investigator award) – fundername: National Cancer Institute and National Institutes of Health funderid: HHSN261200800001E – fundername: NCI NIH HHS grantid: CA53765 – fundername: NCI NIH HHS grantid: CA92258 – fundername: NIAMS NIH HHS grantid: R01 AR047951 – fundername: NCI NIH HHS grantid: R01 CA053765 – fundername: NIAMS NIH HHS grantid: AR47951 – fundername: NCI NIH HHS grantid: R01 CA092258 – fundername: NCI NIH HHS grantid: HHSN261200800001C – fundername: NCI NIH HHS grantid: HHSN261200800001E |
GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGXDD AGYGG AHBTC AHMBA AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 .Y3 5PM |
ID | FETCH-LOGICAL-c5130-8a6f817330b5777896653276b76e57b9e1e9fa551f70cee5fa8ed66ffc4d28103 |
IEDL.DBID | DR2 |
ISSN | 0020-7136 1097-0215 |
IngestDate | Thu Aug 21 17:44:42 EDT 2025 Fri Jul 11 06:27:02 EDT 2025 Fri Jul 25 02:45:40 EDT 2025 Thu Apr 03 07:09:09 EDT 2025 Thu Apr 24 23:08:55 EDT 2025 Tue Jul 01 02:27:47 EDT 2025 Wed Aug 20 07:24:50 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | melanocortin 1 receptor melanoma HGF/Met melanin ultraviolet |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2014 UICC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5130-8a6f817330b5777896653276b76e57b9e1e9fa551f70cee5fa8ed66ffc4d28103 |
Notes | Faith M. Strickland's current address is: Department of Internal Medicine, Rheumatology Division, The University of Michigan, Ann Arbor, MI 48109‐2200 Published 2014. This article is a US Government work and, as such, is in the public domain of the United States of America. Albert Wielgus's current address is: Lineberger Comprehensive Cancer Center, 160 N. Medical Dr., University of North Carolina, Chapel Hill, NC 27599, USA ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Current Address: Lineberger Comprehensive Cancer Center, 160 N. Medical Dr., University of North Carolina, Chapel Hill, NC 27599, USA Current Address: Department of Internal Medicine, Rheumatology Division, The University of Michigan, Ann Arbor, MI 48109-2200 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.29050 |
PMID | 24975581 |
PQID | 1634669195 |
PQPubID | 105430 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4262613 proquest_miscellaneous_1635001675 proquest_journals_1634669195 pubmed_primary_24975581 crossref_primary_10_1002_ijc_29050 crossref_citationtrail_10_1002_ijc_29050 wiley_primary_10_1002_ijc_29050_IJC29050 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 15 February, 2015 |
PublicationDateYYYYMMDD | 2015-02-15 |
PublicationDate_xml | – month: 02 year: 2015 text: 15 February, 2015 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | International journal of cancer |
PublicationTitleAlternate | Int J Cancer |
PublicationYear | 2015 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2010; 11 2004; 64 2013; 26 2004; 84 2012; 487 2013; 22 1978; 75 1996; 93 2006; 5 2005; 65 2006; 19 2003; 994 2013; 8 2006; 313 2012; 10 2006; 332 2008; 283 1993; 101 2011; 131 2007; 16 2007; 28 2012; 491 2013; 19 2011; 301 2012; 132 2012; 3 2011; 129 2004; 279 2010; 24 2011; 469 2012; 212 1993; 72 2002; 62 2005; 146 2005; 124 2005; 125 2010; 312 2013; 51 2010; 130 2007; 81 1997; 192 2011; 25 2009; 129 2008; 40 2001; 413 2001; 10 e_1_2_6_51_1 e_1_2_6_53_1 e_1_2_6_32_1 e_1_2_6_30_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_17_1 e_1_2_6_55_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_43_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_9_1 e_1_2_6_5_1 e_1_2_6_7_1 e_1_2_6_24_1 e_1_2_6_49_1 e_1_2_6_3_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_47_1 e_1_2_6_52_1 e_1_2_6_54_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_50_1 e_1_2_6_14_1 e_1_2_6_35_1 Recio JA (e_1_2_6_19_1) 2002; 62 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_56_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_42_1 e_1_2_6_21_1 e_1_2_6_40_1 Natarajan K (e_1_2_6_48_1) 2006; 332 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_29_1 e_1_2_6_44_1 Yu Y (e_1_2_6_26_1) 2002; 62 e_1_2_6_27_1 e_1_2_6_46_1 |
References_xml | – volume: 212 start-page: 1 year: 2012 end-page: 115 article-title: Sensing the environment: Regulation of local and global homeostasis by the skin's neuroendocrine system publication-title: Adv Anat Embryol Cell Biol – volume: 313 start-page: 521 year: 2006 end-page: 2 article-title: MC1R germline variants confer risk for BRAF‐mutant melanoma publication-title: Science – volume: 16 start-page: 2341 year: 2007 end-page: 8 article-title: Humanized MC1R transgenic mice reveal human specific receptor function publication-title: Hum Mol Genet – volume: 487 start-page: 500 year: 2012 end-page: 4 article-title: Tumour micro‐environment elicits innate resistance to RAF inhibitors through HGF secretion publication-title: Nature – volume: 413 start-page: 271 year: 2001 end-page: 2 article-title: Neonatal sunburn and melanoma in mice publication-title: Nature – volume: 125 start-page: 383 year: 2005 end-page: 5 article-title: SCA‐1+ cells with an adipocyte phenotype in neonatal mouse skin publication-title: J Invest Dermatol – volume: 22 start-page: 226 year: 2013 end-page: 8 article-title: Functional melanocortin 1 receptor Mc1r is not necessary for an inflammatory response to UV radiation in adult mouse skin publication-title: Exp Dermatol – volume: 72 start-page: 827 year: 1993 end-page: 34 article-title: Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function publication-title: Cell – volume: 129 start-page: 1730 year: 2011 end-page: 40 article-title: Melanocortin 1 receptor and risk of cutaneous melanoma: a meta‐analysis and estimates of population burden publication-title: Int J Cancer – volume: 26 start-page: 835 year: 2013 end-page: 44 article-title: The effect of MC1R variants and sunscreen on the response of human melanocytes in vivo to ultraviolet radiation and implications for melanoma publication-title: Pigment Cell Melanoma Res – volume: 132 start-page: 1452 year: 2012 end-page: 61 article-title: MC1R variant allele effects on UVR‐induced phosphorylation of p38, p53, and DDB2 repair protein responses in melanocytic cells in culture publication-title: J Invest Dermatol – volume: 28 start-page: 2387 year: 2007 end-page: 96 article-title: Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways publication-title: Peptides – volume: 3 start-page: 884 year: 2012 article-title: Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment publication-title: Nat Commun – volume: 130 start-page: 1463 year: 2010 end-page: 5 article-title: Relationship between germline MC1R variants and BRAF‐mutant melanoma in a North Carolina population‐based study publication-title: J Invest Dermatol – volume: 64 start-page: 6372 year: 2004 end-page: 6 article-title: Ultraviolet B but not ultraviolet A radiation initiates melanoma publication-title: Cancer Res – volume: 10 start-page: 765 year: 2001 end-page: 71 article-title: Locomotion of human skin keratinocytes on polystyrene, fibrin, and collagen substrata and its modification by cell‐to‐cell contacts publication-title: Cell Transplant – volume: 93 start-page: 5866 year: 1996 end-page: 71 article-title: Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development publication-title: Proc Natl Acad Sci USA – volume: 25 start-page: 138 year: 2011 end-page: 56 article-title: Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen‐activated protein kinases involves transactivation of cKIT publication-title: Mol Endocrinol – volume: 5 start-page: 254 year: 2006 end-page: 60 article-title: Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model publication-title: Photochem Photobiol Sci – volume: 487 start-page: 505 year: 2012 end-page: 9 article-title: Widespread potential for growth‐factor‐driven resistance to anticancer kinase inhibitors publication-title: Nature – volume: 469 start-page: 548 year: 2011 end-page: 53 article-title: Interferon‐gamma links ultraviolet radiation to melanomagenesis in mice publication-title: Nature – volume: 130 start-page: 2844 year: 2010 end-page: 8 article-title: Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors publication-title: J Invest Dermatol – volume: 279 start-page: 28970 year: 2004 end-page: 8 article-title: Reactive oxygen species mediate met receptor transactivation by G protein‐coupled receptors and the epidermal growth factor receptor in human carcinoma cells publication-title: J Biol Chem – volume: 130 start-page: 520 year: 2010 end-page: 8 article-title: Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma publication-title: J Invest Dermatol – volume: 332 start-page: 51 year: 2006 end-page: 77 article-title: Crosstalk coregulation mechanisms of G protein‐coupled receptors and receptor tyrosine kinases publication-title: Methods Mol Biol – volume: 101 start-page: 90S year: 1993 end-page: 97S article-title: Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth publication-title: J Invest Dermatol – volume: 129 start-page: 184 year: 2009 end-page: 93 article-title: Murine neonatal melanocytes exhibit a heightened proliferative response to ultraviolet radiation and migrate to the epidermal basal layer publication-title: J Invest Dermatol – volume: 8 start-page: e74883 year: 2013 article-title: HGF/SF increases number of skin melanocytes but does not alter quality or quantity of follicular melanogenesis publication-title: PLoS One – volume: 283 start-page: 12564 year: 2008 end-page: 70 article-title: Melanocortin‐1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells publication-title: J Biol Chem – volume: 130 start-page: 241 year: 2010 end-page: 8 article-title: The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population publication-title: J Invest Dermatol – volume: 51 start-page: 409 year: 2013 end-page: 22 article-title: MC1R is a potent regulator of PTEN after UV exposure in melanocytes publication-title: Mol Cell – volume: 312 year: 2010 – volume: 146 start-page: 1245 year: 2005 end-page: 53 article-title: Preservation of eumelanin hair pigmentation in propriomelanocortin‐deficient mice on a nonagouti (a/a) genetic background publication-title: Endocrinology – volume: 192 start-page: 99 year: 1997 end-page: 107 article-title: Activation of the receptor tyrosine kinase kit is required for the proliferation of melanoblasts in the mouse embryo publication-title: Dev Biol – volume: 19 start-page: 924 year: 2013 end-page: 9 article-title: Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling publication-title: Nat Med – volume: 132 start-page: 1814 year: 2012 end-page: 24 article-title: α‐MSH‐stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation publication-title: J Invest Dermatol – volume: 10 start-page: 778 year: 2012 end-page: 86 article-title: Alpha‐melanocyte‐stimulating hormone suppresses oxidative stress through a p53‐mediated signaling pathway in human melanocytes publication-title: Mol Cancer Res – volume: 62 start-page: 2951 year: 2002 end-page: 6 article-title: Constitutive c‐met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model publication-title: Cancer Res – volume: 491 start-page: 449 year: 2012 end-page: 53 article-title: An ultraviolet‐radiation‐independent pathway to melanoma carcinogenesis in the red hair/fair skin background publication-title: Nature – volume: 129 start-page: 285 year: 2011 end-page: 94 article-title: Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in hgf‐Cdk4(R24C) C57BL/6 mice publication-title: Int J Cancer – volume: 84 start-page: 1155 year: 2004 end-page: 228 article-title: Melanin pigmentation in mammalian skin and its hormonal regulation publication-title: Physiol Rev – volume: 65 start-page: 4292 year: 2005 end-page: 9 article-title: Alpha‐melanocortin and endothelin‐1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes publication-title: Cancer Res – volume: 994 start-page: 359 year: 2003 end-page: 65 article-title: Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival publication-title: Ann NY Acad Sci – volume: 81 start-page: 1352 year: 2007 end-page: 61 article-title: Deficient inflammatory response to UV radiation in neonatal mice publication-title: J Leukoc Biol – volume: 62 start-page: 6724 year: 2002 end-page: 30 article-title: Ink4a/arf deficiency promotes ultraviolet radiation‐induced melanomagenesis publication-title: Cancer Res – volume: 28 start-page: 495 year: 2007 end-page: 505 article-title: Comprehensive evaluation of allele frequency differences of MC1R variants across populations publication-title: Hum Mutat – volume: 124 start-page: 13 year: 2005 end-page: 21 article-title: Hair follicle pigmentation publication-title: J Invest Dermatol – volume: 24 start-page: 3850 year: 2010 end-page: 60 article-title: Melanocortin 1 receptor genotype: An important determinant of the damage response of melanocytes to ultraviolet radiation publication-title: FASEB J – volume: 131 start-page: 1384 year: 2011 end-page: 7 article-title: Superficial spreading‐like melanoma in arf(‐/‐)::Tyr‐nras(Q61K)::K14‐kitl mice: Keratinocyte kit ligand expression sufficient to "translocate" melanomas from dermis to epidermis publication-title: J Invest Dermatol. – volume: 26 start-page: 723 year: 2013 end-page: 6 article-title: The mouse ruby‐eye 2(d) (ru2(d)/Hps5(ru2‐d) allele inhibits eumelanin but not pheomelanin synthesis publication-title: Pigment Cell Melanoma Res – volume: 75 start-page: 5395 year: 1978 end-page: 9 article-title: Photodestruction of pheomelanin: role of oxygen publication-title: Proc Natl Acad Sci USA – volume: 40 start-page: 104 year: 2008 end-page: 9 article-title: A cis‐acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse publication-title: Nat Genet – volume: 301 start-page: E484 year: 2011 end-page: E493 article-title: Cutaneous hypothalamic‐pituitary‐adrenal axis homolog: Regulation by ultraviolet radiation publication-title: Am J Physiol Endocrinol Metab – volume: 11 start-page: 834 year: 2010 end-page: 48 article-title: MET signalling: principles and functions in development, organ regeneration and cancer publication-title: Nat Rev Mol Cell Biol – volume: 19 start-page: 303 year: 2006 end-page: 14 article-title: Melanin content and MC1R function independently affect UVR‐induced DNA damage in cultured human melanocytes publication-title: Pigment Cell Res – ident: e_1_2_6_27_1 doi: 10.3727/000000001783986251 – ident: e_1_2_6_39_1 doi: 10.1038/nature11183 – ident: e_1_2_6_55_1 doi: 10.1111/pcmr.12157 – ident: e_1_2_6_49_1 doi: 10.1210/me.2010-0217 – ident: e_1_2_6_33_1 doi: 10.1111/pcmr.12118 – ident: e_1_2_6_13_1 doi: 10.1074/jbc.M800480200 – ident: e_1_2_6_14_1 doi: 10.1158/1541-7786.MCR-11-0436 – ident: e_1_2_6_18_1 doi: 10.1158/0008-5472.CAN-04-1454 – ident: e_1_2_6_50_1 doi: 10.1038/jid.2011.21 – ident: e_1_2_6_54_1 doi: 10.1007/978-3-642-19683-6_1 – ident: e_1_2_6_2_1 doi: 10.1111/j.1749-6632.2003.tb03200.x – ident: e_1_2_6_41_1 doi: 10.1016/j.molcel.2013.08.010 – ident: e_1_2_6_47_1 doi: 10.1111/exd.12100 – ident: e_1_2_6_17_1 doi: 10.1038/35095108 – ident: e_1_2_6_37_1 doi: 10.1002/9781444319651 – ident: e_1_2_6_29_1 doi: 10.1189/jlb.1206729 – ident: e_1_2_6_40_1 doi: 10.1038/nature11249 – ident: e_1_2_6_12_1 doi: 10.1111/j.1600-0749.2006.00315.x – ident: e_1_2_6_7_1 doi: 10.1038/jid.2009.258 – volume: 62 start-page: 2951 year: 2002 ident: e_1_2_6_26_1 article-title: Constitutive c‐met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model publication-title: Cancer Res – ident: e_1_2_6_42_1 doi: 10.1038/jid.2009.182 – ident: e_1_2_6_20_1 doi: 10.1038/ncomms1893 – ident: e_1_2_6_24_1 doi: 10.1016/0092-8674(93)90572-8 – ident: e_1_2_6_9_1 doi: 10.1038/nature11624 – ident: e_1_2_6_46_1 doi: 10.1038/jid.2012.59 – ident: e_1_2_6_3_1 doi: 10.1152/physrev.00044.2003 – ident: e_1_2_6_22_1 doi: 10.1371/journal.pone.0074883 – ident: e_1_2_6_44_1 doi: 10.1038/jid.2009.410 – ident: e_1_2_6_51_1 doi: 10.1093/hmg/ddm191 – volume: 62 start-page: 6724 year: 2002 ident: e_1_2_6_19_1 article-title: Ink4a/arf deficiency promotes ultraviolet radiation‐induced melanomagenesis publication-title: Cancer Res – ident: e_1_2_6_23_1 doi: 10.1073/pnas.93.12.5866 – ident: e_1_2_6_4_1 doi: 10.1152/ajpendo.00217.2011 – ident: e_1_2_6_35_1 doi: 10.1038/jid.2008.210 – ident: e_1_2_6_31_1 doi: 10.1002/ijc.25913 – ident: e_1_2_6_11_1 doi: 10.1016/j.peptides.2007.10.003 – ident: e_1_2_6_43_1 doi: 10.1038/jid.2010.242 – volume: 332 start-page: 51 year: 2006 ident: e_1_2_6_48_1 article-title: Crosstalk coregulation mechanisms of G protein‐coupled receptors and receptor tyrosine kinases publication-title: Methods Mol Biol – ident: e_1_2_6_30_1 doi: 10.1039/b506974b – ident: e_1_2_6_10_1 doi: 10.1158/0008-5472.CAN-04-4535 – ident: e_1_2_6_34_1 doi: 10.1038/nm.3194 – ident: e_1_2_6_56_1 doi: 10.1074/jbc.M402508200 – ident: e_1_2_6_32_1 doi: 10.1016/0022-202X(93)90507-E – ident: e_1_2_6_21_1 doi: 10.1038/nrm3012 – ident: e_1_2_6_15_1 doi: 10.1096/fj.10-158485 – ident: e_1_2_6_53_1 doi: 10.1111/j.0022-202X.2004.23528.x – ident: e_1_2_6_52_1 doi: 10.1210/en.2004-0733 – ident: e_1_2_6_36_1 doi: 10.1038/nature09666 – ident: e_1_2_6_8_1 doi: 10.1073/pnas.75.11.5395 – ident: e_1_2_6_25_1 doi: 10.1006/dbio.1997.8738 – ident: e_1_2_6_6_1 doi: 10.1002/ijc.25804 – ident: e_1_2_6_28_1 doi: 10.1111/j.0022-202X.2005.23781.x – ident: e_1_2_6_16_1 doi: 10.1038/jid.2011.473 – ident: e_1_2_6_38_1 doi: 10.1038/ng.185 – ident: e_1_2_6_5_1 doi: 10.1002/humu.20476 – ident: e_1_2_6_45_1 doi: 10.1126/science.1127515 |
SSID | ssj0011504 |
Score | 2.1809225 |
Snippet | Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP‐dependent pathway. MC1R polymorphisms can impair this process,... Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP-dependent pathway. MC1R polymorphisms can impair this process,... Melanocortin 1 receptor (MC1R) signaling stimulates black eumelanin production through a cAMP dependent pathway. MC1R polymorphisms can impair this process,... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 752 |
SubjectTerms | Animals Cancer Female Genotype & phenotype Hepatocyte Growth Factor - physiology HGF/Met Humans Male Medical research melanin Melanins - physiology melanocortin 1 receptor Melanoma Melanoma, Experimental - metabolism Melanoma, Experimental - pathology Mice, Inbred C57BL Mice, Transgenic Proto-Oncogene Proteins c-met - metabolism Receptor, Melanocortin, Type 1 - metabolism Rodents Signal Transduction Skin Neoplasms - metabolism Skin Neoplasms - pathology ultraviolet |
Title | A melanin‐independent interaction between Mc1r and Met signaling pathways is required for HGF‐dependent melanoma |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.29050 https://www.ncbi.nlm.nih.gov/pubmed/24975581 https://www.proquest.com/docview/1634669195 https://www.proquest.com/docview/1635001675 https://pubmed.ncbi.nlm.nih.gov/PMC4262613 |
Volume | 136 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPSAu0PLcUpBBHLhkm4ef4lRVbJdKywFRqQekyLEdkT6y1W5WCE79CfxGfglj51G2BQlxi-SJHTszmc_xzDcAr50VVDomI8aciSinKpLcphHPOC8sOiwqfO7w7AOfHtOjE3ayAW_7XJiWH2L44eYtI3yvvYHrYrl3TRpanZpxquKwX_exWh4QfRyoozzQ6RiY4wg3YrxnFYrTveHOdV90C2DejpP8Hb8GBzS5D5_7R2_jTs7Gq6YYm-83WB3_c25bcK8DpmS_1aRt2HD1A7gz647eH0KzTy7cua6r-ufVj2oontsQTzixaNMjSBf1RWYmWRBdWzJzDfEhItpnvRNf_vir_rYk1ZIsnI9BdpYgaibTwwn2et1nGGl-oR_B8eTdp4Np1JVsiAxDbxhJzUuZiCyLCyaEkLiZYlkqeCG4Y6JQLnGq1IjSShGje2alls5yXpaG2lQmcfYYNut57Z4CSXVqFTXK0jKhpRRKaKmpygyOQQ0tRvCmf3m56fjMfVmN87xlYk5zXMU8rOIIXg2ily2Jx5-EdnsNyDs7XuaIVinnKlFsBC-HZrRAf6yiazdfBRkWsjlQ5kmrMMMouLkVjMlkBGJNlQYBz-693lJXXwLLty8VgFgLpxk05e8Pnr8_OggXO_8u-gzuIvILufkJ24XNZrFyzxFdNcWLYEa_ABMEIwg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQIu5d0uFDCIA5ds8_BT4lIVlm1pekCt1AuKHMcRgTaLdrNCcOIn8Bv5JYydR1kKEuIWKRM7cWYy3zgz3wA8s4Wg0jIZMGZNQDlVgeRFHPCE87xAh0WFqx1Oj_j0hB6cstM1eNHXwrT8EMOGm7MM_712Bu42pHcuWEOrD2Ycq9AF7FdcR2_Xv-Dl24E8ykGdjoM5DDAU4z2vUBjvDJeueqNLEPNypuSvCNa7oMkNeNfffJt58nG8bPKx-fobr-P_Pt1N2OiwKdltlekWrNn6NlxNu7_vd6DZJef2TNdV_ePb92ron9sQxzkxbyskSJf4RVITzYmuC5LahrgsEe0K34nrgPxZf1mQakHm1qUh24IgcCbT1xMc9WJMP9PsXN-Fk8mr471p0HVtCAxDhxhIzUsZiSQJcyaEkBhPsSQWPBfcMpErG1lVagRqpQjRQ7NSS1twXpaGFrGMwuQerNez2m4BiXVcKGpUQcuIllIooaWmKjE4BzU0H8Hz_u1lpqM0d501zrKWjDnOcBUzv4ojeDqIfmp5PP4ktN2rQNaZ8iJDwEo5V5FiI3gynEYjdH9WdG1nSy_DfEEHymy2GjPMgvGtYExGIxArujQIOILv1TN19d4TfbtuAQi38DG9qvz9xrP9gz1_cP_fRR_Dtelxepgd7h-9eQDXEQj6Uv2IbcN6M1_ahwi2mvyRt6mfF74nIg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVqq4QHl22wIGceCSbR5-qqeqsGwLWyFEpR6QIscPEWiz1W5WCE78hP5Gfglj51GWgoS4RfLEjp2ZzOd45huEnlnDibBURJRaHRFGZCSYSSOWMVYYcFiE-9zhyTEbn5CjU3q6gva6XJiGH6L_4eYtI3yvvYFfGLd7RRpaftLDVMZ-v75GGBiLR0Tveu4oj3RaCuY4gp0Y62iF4nS3v3XZGV1DmNcDJX8FsMEDjW6hD92zN4Enn4eLuhjqb7_ROv7n5DbQzRaZ4v1GlW6jFVvdQeuT9uz9Lqr38bk9U1VZ_fh-WfbVc2vsGSdmTX4EbsO-8EQnM6wqgye2xj5GRPm0d-zrH39RX-e4nOOZ9UHI1mCAzXj8agS9XvUZRpqeq3voZPTy_cE4ams2RJqCO4yEYk4kPMvignLOBeymaJZyVnBmKS-kTax0CmCa4zH4Z-qUsIYx5zQxqUji7D5araaV3UQ4VamRREtDXEKc4JIroYjMNIxBNCkG6Hn38nLdEpr7uhpneUPFnOawinlYxQF62oteNCwefxLa6TQgbw15ngNcJYzJRNIBetI3gwn6cxVV2ekiyNCQzgEyDxqF6UeB3S2nVCQDxJdUqRfw9N7LLVX5MdB8-1oBALZgmkFT_v7g-eHRQbjY-nfRx2j97YtR_ubw-PU2ugEoMOTpJ3QHrdazhX0ISKsuHgWL-gmvlSXa |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+melanin-independent+interaction+between+Mc1r+and+Met+signalling+pathways+is+required+for+HGF-dependent+melanoma&rft.jtitle=International+journal+of+cancer&rft.au=Wolnicka-Glubisz%2C+Agnieszka&rft.au=Strickland%2C+Faith+M.&rft.au=Wielgus%2C+Albert&rft.au=Anver%2C+Miriam&rft.date=2015-02-15&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=136&rft.issue=4&rft.spage=752&rft.epage=760&rft_id=info:doi/10.1002%2Fijc.29050&rft_id=info%3Apmid%2F24975581&rft.externalDocID=PMC4262613 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon |